Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Return on Capital Employed (2020 - 2024)

Pulmonx (LUNG) has disclosed Return on Capital Employed for 6 consecutive years, with 0.48% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 9.0% to 0.48% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.48%, a 9.0% decrease, with the full-year FY2024 number at 0.4%, down 1.0% from a year prior.
  • Return on Capital Employed was 0.48% for Q3 2025 at Pulmonx, down from 0.41% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.21% in Q4 2021 to a low of 0.48% in Q3 2025.
  • A 5-year average of 0.37% and a median of 0.39% in 2024 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: changed 0bps in 2021, then decreased -12bps in 2022.
  • Pulmonx's Return on Capital Employed stood at 0.21% in 2021, then crashed by -56bps to 0.33% in 2022, then dropped by -20bps to 0.39% in 2023, then dropped by -5bps to 0.41% in 2024, then fell by -16bps to 0.48% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Return on Capital Employed are 0.48% (Q3 2025), 0.41% (Q4 2024), and 0.38% (Q3 2024).